Found: 1
Select item for more details and to access through your institution.
Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders.
- Published in:
- Rheumatology, 2023, v. 62, n. 7, p. 2544, doi. 10.1093/rheumatology/keac666
- By:
- Publication type:
- Article